nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—SLC18A2—telencephalic ventricle—autistic disorder	0.0362	0.114	CbGeAlD
Dextroamphetamine—SLC6A3—telencephalic ventricle—autistic disorder	0.0274	0.0862	CbGeAlD
Dextroamphetamine—TAAR1—nervous system—autistic disorder	0.0151	0.0476	CbGeAlD
Dextroamphetamine—TAAR1—central nervous system—autistic disorder	0.0145	0.0458	CbGeAlD
Dextroamphetamine—SLC6A3—hindbrain—autistic disorder	0.0129	0.0407	CbGeAlD
Dextroamphetamine—SLC18A2—brainstem—autistic disorder	0.00978	0.0308	CbGeAlD
Dextroamphetamine—ADRA1A—hindbrain—autistic disorder	0.00969	0.0305	CbGeAlD
Dextroamphetamine—SLC18A2—forebrain—autistic disorder	0.00944	0.0298	CbGeAlD
Dextroamphetamine—SLC18A2—telencephalon—autistic disorder	0.00868	0.0274	CbGeAlD
Dextroamphetamine—SLC6A3—brainstem—autistic disorder	0.0074	0.0233	CbGeAlD
Dextroamphetamine—SLC6A3—forebrain—autistic disorder	0.00714	0.0225	CbGeAlD
Dextroamphetamine—SLC18A2—digestive system—autistic disorder	0.00663	0.0209	CbGeAlD
Dextroamphetamine—SLC6A3—telencephalon—autistic disorder	0.00657	0.0207	CbGeAlD
Dextroamphetamine—SLC6A2—brainstem—autistic disorder	0.00597	0.0188	CbGeAlD
Dextroamphetamine—SLC6A2—forebrain—autistic disorder	0.00576	0.0182	CbGeAlD
Dextroamphetamine—CYP2D6—hindbrain—autistic disorder	0.0057	0.018	CbGeAlD
Dextroamphetamine—ADRA1A—brainstem—autistic disorder	0.00555	0.0175	CbGeAlD
Dextroamphetamine—ADRA1B—head—autistic disorder	0.00546	0.0172	CbGeAlD
Dextroamphetamine—SLC18A2—head—autistic disorder	0.00541	0.017	CbGeAlD
Dextroamphetamine—ADRA1A—forebrain—autistic disorder	0.00536	0.0169	CbGeAlD
Dextroamphetamine—SLC6A2—telencephalon—autistic disorder	0.0053	0.0167	CbGeAlD
Dextroamphetamine—ADRA1B—nervous system—autistic disorder	0.00518	0.0163	CbGeAlD
Dextroamphetamine—SLC18A2—nervous system—autistic disorder	0.00513	0.0162	CbGeAlD
Dextroamphetamine—ADRA1B—central nervous system—autistic disorder	0.00498	0.0157	CbGeAlD
Dextroamphetamine—SLC18A2—central nervous system—autistic disorder	0.00494	0.0156	CbGeAlD
Dextroamphetamine—ADRA1A—telencephalon—autistic disorder	0.00493	0.0155	CbGeAlD
Dextroamphetamine—SLC18A2—cerebellum—autistic disorder	0.00482	0.0152	CbGeAlD
Dextroamphetamine—SLC6A3—head—autistic disorder	0.00409	0.0129	CbGeAlD
Dextroamphetamine—ADRA1B—brain—autistic disorder	0.00396	0.0125	CbGeAlD
Dextroamphetamine—SLC18A2—brain—autistic disorder	0.00392	0.0124	CbGeAlD
Dextroamphetamine—SLC6A3—nervous system—autistic disorder	0.00388	0.0122	CbGeAlD
Dextroamphetamine—SLC6A3—central nervous system—autistic disorder	0.00373	0.0118	CbGeAlD
Dextroamphetamine—SLC6A3—cerebellum—autistic disorder	0.00365	0.0115	CbGeAlD
Dextroamphetamine—SLC6A2—head—autistic disorder	0.0033	0.0104	CbGeAlD
Dextroamphetamine—CYP2D6—brainstem—autistic disorder	0.00327	0.0103	CbGeAlD
Dextroamphetamine—CYP2D6—forebrain—autistic disorder	0.00316	0.00995	CbGeAlD
Dextroamphetamine—SLC6A2—nervous system—autistic disorder	0.00313	0.00986	CbGeAlD
Dextroamphetamine—ADRA1A—head—autistic disorder	0.00307	0.00967	CbGeAlD
Dextroamphetamine—SLC6A2—central nervous system—autistic disorder	0.00301	0.00949	CbGeAlD
Dextroamphetamine—SLC6A3—brain—autistic disorder	0.00296	0.00934	CbGeAlD
Dextroamphetamine—ADRA1A—nervous system—autistic disorder	0.00291	0.00917	CbGeAlD
Dextroamphetamine—CYP2D6—telencephalon—autistic disorder	0.0029	0.00915	CbGeAlD
Dextroamphetamine—ADRA1A—central nervous system—autistic disorder	0.0028	0.00883	CbGeAlD
Dextroamphetamine—Pargyline—MAOB—autistic disorder	0.00277	0.0903	CrCbGaD
Dextroamphetamine—ADRA1A—cerebellum—autistic disorder	0.00274	0.00863	CbGeAlD
Dextroamphetamine—Phenelzine—ABAT—autistic disorder	0.00261	0.0849	CrCbGaD
Dextroamphetamine—SLC6A2—brain—autistic disorder	0.00239	0.00754	CbGeAlD
Dextroamphetamine—Pseudoephedrine—IL2—autistic disorder	0.00236	0.0769	CrCbGaD
Dextroamphetamine—ADRA1A—brain—autistic disorder	0.00222	0.00701	CbGeAlD
Dextroamphetamine—CYP2D6—digestive system—autistic disorder	0.00221	0.00698	CbGeAlD
Dextroamphetamine—Pargyline—MAOA—autistic disorder	0.00194	0.0633	CrCbGaD
Dextroamphetamine—CYP2D6—head—autistic disorder	0.00181	0.0057	CbGeAlD
Dextroamphetamine—Tranylcypromine—MAOB—autistic disorder	0.00179	0.0582	CrCbGaD
Dextroamphetamine—CYP2D6—nervous system—autistic disorder	0.00171	0.0054	CbGeAlD
Dextroamphetamine—CYP2D6—central nervous system—autistic disorder	0.00165	0.0052	CbGeAlD
Dextroamphetamine—CYP2D6—cerebellum—autistic disorder	0.00161	0.00508	CbGeAlD
Dextroamphetamine—Phentermine—MAOB—autistic disorder	0.0015	0.0487	CrCbGaD
Dextroamphetamine—Selegiline—MAOB—autistic disorder	0.00138	0.0451	CrCbGaD
Dextroamphetamine—CYP2D6—brain—autistic disorder	0.00131	0.00413	CbGeAlD
Dextroamphetamine—Tranylcypromine—MAOA—autistic disorder	0.00125	0.0408	CrCbGaD
Dextroamphetamine—Phenelzine—MAOB—autistic disorder	0.00122	0.0397	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—MAOA—autistic disorder	0.00118	0.0383	CrCbGaD
Dextroamphetamine—Amphetamine—MAOB—autistic disorder	0.00115	0.0375	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—DRD1—autistic disorder	0.00107	0.0349	CrCbGaD
Dextroamphetamine—Methamphetamine—MAOB—autistic disorder	0.00107	0.0347	CrCbGaD
Dextroamphetamine—Phentermine—MAOA—autistic disorder	0.00105	0.0342	CrCbGaD
Dextroamphetamine—Pseudoephedrine—MAOA—autistic disorder	0.000995	0.0324	CrCbGaD
Dextroamphetamine—Selegiline—MAOA—autistic disorder	0.000971	0.0316	CrCbGaD
Dextroamphetamine—Ephedrine—ADRB2—autistic disorder	0.000932	0.0304	CrCbGaD
Dextroamphetamine—Phenelzine—MAOA—autistic disorder	0.000855	0.0279	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—ADRB2—autistic disorder	0.000836	0.0272	CrCbGaD
Dextroamphetamine—Methamphetamine—MAOA—autistic disorder	0.000748	0.0244	CrCbGaD
Dextroamphetamine—Pseudoephedrine—ADRB2—autistic disorder	0.000706	0.023	CrCbGaD
Dextroamphetamine—Phentermine—SLC6A4—autistic disorder	0.000677	0.022	CrCbGaD
Dextroamphetamine—Pseudoephedrine—SLC6A4—autistic disorder	0.000641	0.0209	CrCbGaD
Dextroamphetamine—Amphetamine—SLC6A4—autistic disorder	0.00052	0.0169	CrCbGaD
Dextroamphetamine—Methamphetamine—SLC6A4—autistic disorder	0.000482	0.0157	CrCbGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—SCT—autistic disorder	0.000136	0.000208	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AVPR1A—autistic disorder	0.000133	0.000204	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—BTD—autistic disorder	0.000132	0.000203	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GABBR1—autistic disorder	0.000132	0.000203	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADM—autistic disorder	0.000132	0.000203	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NRP2—autistic disorder	0.000132	0.000203	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—AVP—autistic disorder	0.000132	0.000202	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—AVP—autistic disorder	0.000132	0.000202	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PRKCB—autistic disorder	0.00013	0.000199	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADM—autistic disorder	0.00013	0.000199	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GABBR1—autistic disorder	0.00013	0.000199	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	0.000129	0.000198	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PDE4B—autistic disorder	0.000129	0.000198	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—VIP—autistic disorder	0.000129	0.000197	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GRM5—autistic disorder	0.000129	0.000197	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR5A—autistic disorder	0.000127	0.000195	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PDE4B—autistic disorder	0.000126	0.000194	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—OPRM1—autistic disorder	0.000125	0.000192	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—OXTR—autistic disorder	0.000125	0.000191	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CG—autistic disorder	0.000124	0.00019	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—APC—autistic disorder	0.000124	0.00019	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—HRAS—autistic disorder	0.000124	0.00019	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR2A—autistic disorder	0.000123	0.000189	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—SCT—autistic disorder	0.000123	0.000189	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—EGF—autistic disorder	0.000123	0.000188	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—OPRM1—autistic disorder	0.000122	0.000188	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—OXT—autistic disorder	0.000122	0.000187	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR1B—autistic disorder	0.000122	0.000187	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GABBR2—autistic disorder	0.000121	0.000186	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—autistic disorder	0.00012	0.000184	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—POMC—autistic disorder	0.000118	0.000181	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GABBR1—autistic disorder	0.000118	0.00018	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADM—autistic disorder	0.000118	0.00018	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	0.000115	0.000176	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PDE4B—autistic disorder	0.000115	0.000176	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—DRD1—autistic disorder	0.000114	0.000174	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IGF1—autistic disorder	0.000114	0.000174	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—MAPK1—autistic disorder	0.000113	0.000173	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TDO2—autistic disorder	0.000113	0.000173	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—POMC—autistic disorder	0.000112	0.000172	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—OPRM1—autistic disorder	0.000111	0.00017	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR1B—autistic disorder	0.000111	0.00017	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—OXT—autistic disorder	0.000111	0.00017	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—DRD3—autistic disorder	0.00011	0.000169	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR2A—autistic disorder	0.00011	0.000168	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR1B—autistic disorder	0.000109	0.000166	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—OXT—autistic disorder	0.000109	0.000166	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR1D—autistic disorder	0.000108	0.000166	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GABBR2—autistic disorder	0.000108	0.000165	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SERPINE1—autistic disorder	0.000108	0.000165	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL5—autistic disorder	0.000108	0.000165	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CALCA—autistic disorder	0.000106	0.000163	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DHCR7—autistic disorder	0.000106	0.000162	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRLR—autistic disorder	0.000104	0.00016	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—DRD1—autistic disorder	0.000103	0.000158	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—DRD1—autistic disorder	0.000101	0.000155	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GRM8—autistic disorder	0.000101	0.000154	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC6A8—autistic disorder	0.0001	0.000154	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—EXT1—autistic disorder	0.0001	0.000154	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—DRD3—autistic disorder	9.99e-05	0.000153	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	9.88e-05	0.000152	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR1B—autistic disorder	9.86e-05	0.000151	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—OXT—autistic disorder	9.86e-05	0.000151	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—POMC—autistic disorder	9.85e-05	0.000151	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL5—autistic disorder	9.78e-05	0.00015	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—DRD3—autistic disorder	9.77e-05	0.00015	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—WNT2—autistic disorder	9.74e-05	0.000149	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CALCA—autistic disorder	9.66e-05	0.000148	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—autistic disorder	9.65e-05	0.000148	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR1D—autistic disorder	9.61e-05	0.000147	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GHR—autistic disorder	9.6e-05	0.000147	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DAO—autistic disorder	9.58e-05	0.000147	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL5—autistic disorder	9.57e-05	0.000147	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDE4A—autistic disorder	9.46e-05	0.000145	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CALCA—autistic disorder	9.45e-05	0.000145	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRLR—autistic disorder	9.25e-05	0.000142	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—MAPK1—autistic disorder	9.21e-05	0.000141	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—UPB1—autistic disorder	9.18e-05	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—DRD1—autistic disorder	9.17e-05	0.000141	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HRAS—autistic disorder	9.07e-05	0.000139	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GRM8—autistic disorder	8.94e-05	0.000137	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADRB2—autistic disorder	8.92e-05	0.000137	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—DRD3—autistic disorder	8.88e-05	0.000136	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AVPR1A—autistic disorder	8.86e-05	0.000136	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	8.78e-05	0.000135	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—POMC—autistic disorder	8.75e-05	0.000134	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL2—autistic disorder	8.73e-05	0.000134	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL5—autistic disorder	8.69e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL6—autistic disorder	8.68e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—WNT2—autistic disorder	8.65e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CALCA—autistic disorder	8.58e-05	0.000132	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VIP—autistic disorder	8.55e-05	0.000131	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GRM5—autistic disorder	8.55e-05	0.000131	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ASMT—autistic disorder	8.54e-05	0.000131	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTM5—autistic disorder	8.54e-05	0.000131	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GHR—autistic disorder	8.53e-05	0.000131	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDE4A—autistic disorder	8.4e-05	0.000129	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AVP—autistic disorder	8.38e-05	0.000128	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—OXTR—autistic disorder	8.29e-05	0.000127	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PTEN—autistic disorder	8.21e-05	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SCT—autistic disorder	8.2e-05	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADRB2—autistic disorder	8.1e-05	0.000124	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC25A12—autistic disorder	8.03e-05	0.000123	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	7.93e-05	0.000122	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADRB2—autistic disorder	7.92e-05	0.000121	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AVPR1A—autistic disorder	7.87e-05	0.000121	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADM—autistic disorder	7.82e-05	0.00012	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GABBR1—autistic disorder	7.82e-05	0.00012	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC19A1—autistic disorder	7.81e-05	0.00012	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EIF4E—autistic disorder	7.69e-05	0.000118	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDE4B—autistic disorder	7.62e-05	0.000117	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AVP—autistic disorder	7.61e-05	0.000117	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GRM5—autistic disorder	7.6e-05	0.000117	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VIP—autistic disorder	7.6e-05	0.000117	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	7.59e-05	0.000116	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AVP—autistic disorder	7.44e-05	0.000114	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—HRAS—autistic disorder	7.39e-05	0.000113	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—OPRM1—autistic disorder	7.38e-05	0.000113	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—OXTR—autistic disorder	7.36e-05	0.000113	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SCT—autistic disorder	7.29e-05	0.000112	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADRB2—autistic disorder	7.19e-05	0.00011	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PLA2G4A—autistic disorder	7.15e-05	0.00011	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	7.04e-05	0.000108	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR2A—autistic disorder	6.97e-05	0.000107	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ADSL—autistic disorder	6.96e-05	0.000107	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GABBR1—autistic disorder	6.95e-05	0.000107	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADM—autistic disorder	6.95e-05	0.000107	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EIF4E—autistic disorder	6.83e-05	0.000105	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—XDH—autistic disorder	6.83e-05	0.000105	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDE4B—autistic disorder	6.77e-05	0.000104	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AVP—autistic disorder	6.76e-05	0.000104	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GZMB—autistic disorder	6.75e-05	0.000104	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	6.74e-05	0.000103	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—STX1A—autistic disorder	6.7e-05	0.000103	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NPAS2—autistic disorder	6.7e-05	0.000103	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MAPK1—autistic disorder	6.68e-05	0.000102	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—OPRM1—autistic disorder	6.56e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR1B—autistic disorder	6.56e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—OXT—autistic disorder	6.56e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TCN2—autistic disorder	6.47e-05	9.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PLA2G4A—autistic disorder	6.35e-05	9.74e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR2A—autistic disorder	6.33e-05	9.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR2A—autistic disorder	6.19e-05	9.5e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ADA—autistic disorder	6.17e-05	9.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PRKCB—autistic disorder	6.11e-05	9.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TSC1—autistic disorder	6.1e-05	9.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DRD1—autistic disorder	6.1e-05	9.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GZMB—autistic disorder	6e-05	9.2e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NTRK2—autistic disorder	5.93e-05	9.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DRD3—autistic disorder	5.9e-05	9.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CG—autistic disorder	5.85e-05	8.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR1B—autistic disorder	5.82e-05	8.93e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—OXT—autistic disorder	5.82e-05	8.93e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL5—autistic disorder	5.78e-05	8.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CALCA—autistic disorder	5.71e-05	8.75e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—RORA—autistic disorder	5.63e-05	8.63e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR2A—autistic disorder	5.62e-05	8.62e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—POMC—autistic disorder	5.57e-05	8.54e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PRKCB—autistic disorder	5.55e-05	8.51e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PRKCB—autistic disorder	5.43e-05	8.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TSC1—autistic disorder	5.41e-05	8.3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD1—autistic disorder	5.41e-05	8.3e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HRAS—autistic disorder	5.36e-05	8.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CG—autistic disorder	5.31e-05	8.14e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MAOB—autistic disorder	5.27e-05	8.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NTRK2—autistic disorder	5.27e-05	8.08e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD3—autistic disorder	5.24e-05	8.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CG—autistic disorder	5.19e-05	7.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL5—autistic disorder	5.13e-05	7.87e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—autistic disorder	5.13e-05	7.87e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CALCA—autistic disorder	5.07e-05	7.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—POMC—autistic disorder	5.06e-05	7.75e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRL—autistic disorder	5.04e-05	7.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—POMC—autistic disorder	4.94e-05	7.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PRKCB—autistic disorder	4.93e-05	7.56e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TPH2—autistic disorder	4.9e-05	7.52e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DPYD—autistic disorder	4.82e-05	7.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRB2—autistic disorder	4.78e-05	7.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CG—autistic disorder	4.72e-05	7.23e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AVP—autistic disorder	4.49e-05	6.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—POMC—autistic disorder	4.49e-05	6.89e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CACNA1C—autistic disorder	4.49e-05	6.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRL—autistic disorder	4.48e-05	6.87e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF2—autistic disorder	4.47e-05	6.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRB2—autistic disorder	4.25e-05	6.52e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLA2G4A—autistic disorder	4.23e-05	6.48e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL2—autistic disorder	4.12e-05	6.31e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MEF2C—autistic disorder	4.11e-05	6.3e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DHFR—autistic disorder	4.08e-05	6.26e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ITGB3—autistic disorder	4.01e-05	6.14e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AVP—autistic disorder	3.99e-05	6.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF2—autistic disorder	3.97e-05	6.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLA2G4A—autistic disorder	3.75e-05	5.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2A—autistic disorder	3.74e-05	5.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL2—autistic disorder	3.74e-05	5.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL2—autistic disorder	3.66e-05	5.61e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MEF2C—autistic disorder	3.65e-05	5.6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ITGB3—autistic disorder	3.56e-05	5.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TSC2—autistic disorder	3.55e-05	5.45e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOE—autistic disorder	3.48e-05	5.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LEP—autistic disorder	3.48e-05	5.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2A—autistic disorder	3.32e-05	5.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL2—autistic disorder	3.32e-05	5.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCB—autistic disorder	3.28e-05	5.03e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP19A1—autistic disorder	3.2e-05	4.9e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TSC2—autistic disorder	3.16e-05	4.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APC—autistic disorder	3.14e-05	4.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CG—autistic disorder	3.14e-05	4.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGF—autistic disorder	3.1e-05	4.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOE—autistic disorder	3.09e-05	4.74e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LEP—autistic disorder	3.09e-05	4.74e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—POMC—autistic disorder	2.99e-05	4.58e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—COMT—autistic disorder	2.97e-05	4.56e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTP1—autistic disorder	2.96e-05	4.53e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MAOA—autistic disorder	2.95e-05	4.52e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	2.91e-05	4.47e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAT—autistic disorder	2.88e-05	4.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1—autistic disorder	2.87e-05	4.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	2.86e-05	4.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APC—autistic disorder	2.79e-05	4.27e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	2.79e-05	4.27e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGF—autistic disorder	2.75e-05	4.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	2.73e-05	4.18e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTM1—autistic disorder	2.72e-05	4.17e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PLA2G4A—autistic disorder	2.72e-05	4.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—POMC—autistic disorder	2.65e-05	4.07e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GPX1—autistic disorder	2.6e-05	3.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1—autistic disorder	2.55e-05	3.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	2.54e-05	3.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	2.42e-05	3.72e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—autistic disorder	2.4e-05	3.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	2.3e-05	3.52e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOE—autistic disorder	2.24e-05	3.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL2—autistic disorder	2.21e-05	3.39e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—autistic disorder	2.2e-05	3.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTEN—autistic disorder	2.08e-05	3.19e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	2.04e-05	3.13e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CG—autistic disorder	2.02e-05	3.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL2—autistic disorder	1.96e-05	3.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—autistic disorder	1.95e-05	2.99e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—POMC—autistic disorder	1.92e-05	2.95e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTEN—autistic disorder	1.85e-05	2.83e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	1.69e-05	2.59e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—autistic disorder	1.53e-05	2.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	1.5e-05	2.3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HRAS—autistic disorder	1.36e-05	2.08e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTEN—autistic disorder	1.34e-05	2.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—autistic disorder	1.3e-05	1.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HRAS—autistic disorder	1.2e-05	1.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—autistic disorder	1.15e-05	1.77e-05	CbGpPWpGaD
